Stay updated with breaking news from Nasdaq Blte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belite Bio (NASDAQ:BLTE – Get Rating) had its price target reduced by equities researchers at HC Wainwright from $58.00 to $55.00 in a research note issued on Monday, The Fly reports. HC Wainwright’s target price suggests a potential upside of 264.24% from the company’s previous close. HC Wainwright also issued estimates for Belite Bio’s Q1 […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 27,200 shares, a decrease of 18.6% from the April 30th total of 33,400 shares. Based on an average daily volume of 11,900 shares, the […]
Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Rating) were up 4.6% during mid-day trading on Wednesday . The company traded as high as $24.23 and last traded at $23.80. Approximately 4,581 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 10,247 shares. The stock had previously closed […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares saw unusually-high trading volume on Monday . Approximately 5,918 shares were traded during trading, a decline of 40% from the previous session’s volume of 9,866 shares.The stock last traded at $26.15 and had previously closed at $25.54. Analysts Set New Price Targets A number of equities analysts […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares gapped up before the market opened on Friday . The stock had previously closed at $26.22, but opened at $27.03. Belite Bio shares last traded at $26.75, with a volume of 1,504 shares traded. Wall Street Analysts Forecast Growth Several analysts have recently issued reports on the […]